| CONSENSUS | Cooperative North Scandinavian Enalapril Survival Study |
|---|---|
| Tabs | tablets |
| SDZ | Sulfadiazine |
|---|---|
| SDZ | Sulphadiazine |
| E | Enalapril |
| EN | Enalapril |
| ENA | Enalapril |
| peptolide SDZ 214-103 synthetase | <chemical> Catalyses at least 39 partial reaction steps in the synthesis of sdz 214-103 by the fungus cylindrotrichum oligospermum Chemical name: synthetase, peptolide Synonym: sdz 214-103 synthetase (26 Jun 1999) |
|---|---|
| SDZ 90-215 synthetase | <enzyme> Catalyses the synthesis of sdz 90-215 in the fungus septoria Registry number: EC 6.3.2.- (26 Jun 1999) |
| enalapril | <chemical> Orally active inhibitor of kininase II. It controls essential and renal hypertension, improves glomerular filtration rate and effective renal blood flow, and decreases renal vascular resistance without producing adverse effects on salt and water excretion or body fluid composition. Pharmacological action: angiotensin-converting enzyme inhibitors, antihypertensive agents. Chemical name: L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)- (12 Dec 1998) |
| enalapril maleate | L-Proline, 1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-,(S)-, (Z)-2-butenedioate (1:1);a prodrug for enalaprilat, an angiotensin-converting enzyme inhibitor used as an anti-hypertensive agent. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
산도스에날라프릴정 - 새창
|
헥살 A/G |
W25590021 | Enalapril maleate | 전문의약품 | 급여 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|